BioAge Meeting

Thank you Kristen Fortney and BioAge Labs for a fantastic gathering of friends, old and new, with a timely topic: "Extending Human Healthspan: Beyond Weight Loss to Metabolic Resilience." Great timing on the day BioAge was 9% above its IPO price after an almost 400% increase from its low. NLRP3 is hot!

On the panel: Christopher O'Donnell (Novartis), Mark Pruzanski, MA, MD (Alentis Therapeutics), the always insightful Michael Snyder (Stanford University School of Medicine) and Dr. Hanadie Yousef (Juvena Therapeutics, hot off their $33.5m Series B).

One overall message: holistic (cardio-)metabolic health, including non-medical interventions, and orthogonal approaches to GLP-1 to address muscle loss and other side effects.